Performance of a universal prenatal screening program incorporating cell-free fetal DNA analysis in Ontario, Canada

Abstract

This publicly funded screening program, incorporating cfDNA analysis for common aneuploidies, showed robust performance, a substantial reduction in invasive prenatal diagnostic testing and that pregnant people exercise autonomy in their choices about prenatal screening and diagnosis.